| Target Price | $13.26 |
| Price | $10.48 |
| Potential |
26.53%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Ardent Health Inc 2027 .
The average Ardent Health Inc target price is $13.26.
This is
26.53%
register free of charge
$14.70
40.27%
register free of charge
$10.10
3.63%
register free of charge
|
|
| A rating was issued by 18 analysts: 12 Analysts recommend Ardent Health Inc to buy, 5 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ardent Health Inc stock has an average upside potential 2027 of
26.53%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 6.32 | 6.59 |
| 6.01% | 4.20% | |
| EBITDA Margin | 7.61% | 7.78% |
| 17.76% | 2.23% | |
| Net Margin | 2.15% | 2.05% |
| 39.09% | 4.54% |
13 Analysts have issued a sales forecast Ardent Health Inc 2026 . The average Ardent Health Inc sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Ardent Health Inc EBITDA forecast 2026. The average Ardent Health Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Ardent Health Inc Analysts have issued a net profit forecast 2026. The average Ardent Health Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.96 | 0.95 |
| 39.24% | 1.04% | |
| P/E | 11.02 | |
| EV/Sales | 0.28 |
13 Analysts have issued a Ardent Health Inc forecast for earnings per share. The average Ardent Health Inc EPS is
This results in the following potential growth metrics and future valuations:
Ardent Health Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Leerink Partners |
Locked
➜
Locked
|
Locked | Sep 18 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jul 14 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| UBS |
Locked
➜
Locked
|
Locked | May 07 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Sep 18 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jul 14 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
May 07 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


